Modern Early Data The coronavirus vaccine suggests that it is more than 94% effective at preventing infection.
the announcement The company’s vaccine is 94.5% effective, following a similar announcement by pharmaceutical company Pfizer last week that its COVID-19 vaccine is 90% effective at preventing infection.
Preliminary results from Moderna’s 30,000-person test suggest that the vaccine saved people from getting both mild and severe forms of COVID-19. Half the participants were given a placebo and over several months, 90 of them became ill with coronovirus.
Cartoon on coronovirus
The other half of the participants were vaccinated and five of them developed COVID-19. The company said that 11 of the participants who received the placebo became seriously ill, but none of the participants who took the shot became seriously ill.
Modern stated that while a small percentage of participants receiving the vaccine, mRNA-1273, experienced mild side effects such as body aches and headaches, the vaccine had no significant side effects.
The company plans that it can apply for authorization for its vaccine from the Food and Drug Administration after collecting more safety data this month.
In addition to being slightly more effective than Pfizer, Modern’s vaccine can be stored in a freezer that is often available in doctors’ offices and pharmacies, while Pfizer’s vaccine needs to be stored in a freezer that is much cooler. And are not widely available.
Modern also announced The vaccine can then be stored in a standard home or medical refrigerator for 30 days compared to Pfizer’s five days.